Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams

被引:41
|
作者
Villar, HE [1 ]
Danel, F [1 ]
Livermore, DM [1 ]
机构
[1] ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,DEPT MED MICROBIOL,ANTIBIOT GRP,LONDON E1 2AD,ENGLAND
关键词
D O I
10.1093/jac/40.3.365
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An imipenem-resistant mutant of Proteus mirabilis lacked a 26 kDa outer membrane protein (OMP). It has previously been postulated that this protein is a porin, but the present mutant, which was cross-resistant to mecillinam but not to other beta-lactams, proved as permeable to carbapenems as its parent. A mecillinam-selected mutant had similar cross-resistance yet retained the 26 kDa OMP, confirming that this protein was not important to resistance. in contrast, cefoxitin-selected mutants retained the 26 kDa protein but had diminished expression of major 41 and 44 kDa OMPs and showed reduced uptake of carbapenems, although this promoted resistance only when a carbapenemase was also present. We conclude that the imipenem-selected mutant owed its resistance to some factor other than porin loss, probably to a lesion in penicillin-binding protein 2.
引用
收藏
页码:365 / 370
页数:6
相关论文
共 50 条
  • [41] RESISTANCE OF PSEUDOMONAS-AERUGINOSA TO NEW BETA-LACTAMASE-RESISTANT BETA-LACTAMS
    GODFREY, AJ
    BRYAN, LE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 485 - 488
  • [42] RESISTANCE TO BETA-LACTAMS IN ENTEROBACTERIACEAE - DISTRIBUTION OF PHENOTYPES RELATED TO BETA-LACTAMASE PRODUCTION
    SIROT, D
    SIROT, J
    SAULNIER, P
    JOLY, B
    CHANAL, M
    CLUZEL, M
    CLUZEL, R
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1986, 14 (04) : 193 - 199
  • [43] Enzymatic resistance of Escherichia coli to beta-lactams and clinical prevalence.
    Lavigne, JP
    Sotto, A
    Merle, C
    Jourdan, J
    Soussy, CJ
    Sirot, D
    PATHOLOGIE BIOLOGIE, 2002, 50 (06): : 388 - 393
  • [44] Impact of pharmacodynamics on antimicrobial susceptibility and resistance - Beta-lactams, macrolides, and quinolones
    Nightingale, CH
    INFECTIONS IN MEDICINE, 1998, 15 : 54 - 61
  • [45] RESISTANCE TO CEFOTAXIME AND 7 OTHER BETA-LACTAMS IN MEMBERS OF THE FAMILY ENTEROBACTERIACEAE - A 3-YEAR SURVEY IN FRANCE
    SIROT, DL
    GOLDSTEIN, FW
    SOUSSY, CJ
    COURTIEU, AL
    HUSSON, MO
    LEMOZY, J
    MEYRAN, M
    MOREL, C
    PEREZ, R
    QUENTINNOURY, C
    REVERDY, ME
    SCHEFTEL, JM
    ROSEMBAUM, M
    REZVANI, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) : 1677 - 1681
  • [46] IMIPENEM RESISTANCE IN CLINICAL ISOLATES OF PROTEUS-MIRABILIS ASSOCIATED WITH ALTERATIONS IN PENICILLIN-BINDING PROTEINS
    NEUWIRTH, C
    SIEBOR, E
    DUEZ, JM
    PECHINOT, A
    KAZMIERCZAK, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (02) : 335 - 342
  • [47] Patients with piperacillin-tazobactam allergy labels tolerate other beta-lactams
    Taggart, Michael
    Hew, Mark
    Zubrinich, Celia
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (07): : 521 - 523
  • [48] ALLERGY TO CEFAZOLIN - STUDY OF INVIVO CROSS-REACTIVITY WITH OTHER BETA-LACTAMS
    IGEA, JM
    FRAJ, J
    DAVILA, I
    CUEVAS, M
    CUESTA, J
    HINOJOSA, M
    ANNALS OF ALLERGY, 1992, 68 (06): : 515 - 519
  • [49] THE ACTIVITY OF CEFTAZIDIME, OTHER BETA-LACTAMS, AND AMINOGLYCOSIDES AGAINST PSEUDOMONAS-AERUGINOSA
    ROLSTON, KVI
    CHANDRASEKAR, PH
    LEFROCK, JL
    SCHELL, RF
    CHEMOTHERAPY, 1984, 30 (01) : 31 - 34
  • [50] AZTREONAM FOR CYSTIC-FIBROSIS PATIENTS WHO ARE HYPERSENSITIVE TO OTHER BETA-LACTAMS
    JENSEN, T
    KOCH, C
    PEDERSEN, SS
    HOIBY, N
    LANCET, 1987, 1 (8545): : 1319 - 1320